Harris has reaped a windfall of campaign funds since Democrats backed her to replace President Joe Biden after he withdrew ...

Cantor Fitzgerald initiated coverage of Amgen with an Overweight rating and $405 price target. The firm views Amgen’s obesity ...

Fintel reports that on September 27, 2024, Cantor Fitzgerald initiated coverage of Amgen (NasdaqGS:AMGN) with a Overweight ...

On Sept. 27, Howard Lutnick, the CEO of financial Cantor Fitzgerald, appeared on Fox Business and urged regulators to ...

Cantor Fitzgerald has recently initiated Innoviva Inc (INVA) stock to Overweight rating, as announced on June 18, 2024, according to Finviz. Earlier, on July 20, 2022, Goldman had initiated the stock ...

On Thursday, Tripadvisor Inc Common Stock (TRIP) stock saw a modest uptick, ending the day at $14.57 which represents a slight increase of $0.14 or 0.97% from the prior close of $14.43. The stock ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The most significant contributor to the rating is the parent firm's five-year risk-adjusted success ratio of ...

As the crypto industry gears up for the 2024 election, there’s a growing narrative that a win for former President Donald ...

The stock market has been on a breathtaking run, but some stocks have additional upside ahead, according to Wall Street.

Rocket Lab USA Inc. (NASDAQ: RKLB) shareholders recently saw RKLB stock hit a new 52-week high of $8.98 per share. As of this writing, it's pulled back a little to $8.69 per share but is still one of ...

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

Amgen (AMGN) is up more than +1% after Cantor Fitzgerald initiated coverage on the stock with a recommendation of overweight with a price target of $405. HP Inc. (HPQ) is down more than -4% to lead ...